Viral factors and outcomes of chronic HBV infection

American Journal of Gastroenterology

Volumn 106, Issue 1, 2011, Pages 93-95

  Huang, Yuehua ^a   Lok, Anna S F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

DISEASE ASSOCIATION; HEPATITIS B; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX;

EID: 78650993715     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.404     Document Type: Review

References (18)

1. Yang HI, Lu SN, Liaw YF et al. Hepatitis Beantigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-74.
2. Chen YC, Chu CM, Liaw YF. Age-specific prognosis following spontaneous hepatitis Beantigen seroconversion in chronic hepatitis B. Hepatology 2009; 51: 435-44.
3. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
4. Iloeje UH, Yang HI, Su J et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-86.
5. Iloeje UH, Yang HI, Jen CL et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007; 5: 921-31.
6. Yang HI, Yeh SH, Chen PJ et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 1134-43.
7. Sumi H, Yokosuka O, Seki N et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003; 37: 19-26.
8. Livingston SE, Simonetti JP, McMahon BJ et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 2007; 195: 5-11.
9. Kew MC, Yu MC, Kedda MA et al. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997; 112: 184-7.
10. Chou YC, Yu MW, Wu CF et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008; 57: 91-7.
11. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-60.
12. Chu CJ, Keeffe EB, Han SH et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38: 619-28.
13. Yotsuyanagi H, Hino K, Tomita E et al. Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol 2002; 37: 355-63.
14. Fang ZL, Sabin CA, Dong BQ et al. The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis. J Hepatol 2009; 50: 273-80.
15. Fang ZL, Sabin CA, Dong BQ et al. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol 2008; 103: 2254-62.
16. Liu S, Zhang H, Gu C et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009; 101: 1066-82.
17. Guo X, Jin Y, Qian G et al. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 2008; 49: 718-25.
18. Yin J, Xie J, Liu S et al. Association between the various mutations in viral core promoter region to different stages of heaptitis B, ranging of asyptomatic carriers state to hepatocellular carcinoma. Am J Gastro enterol 2010;106:81-92 (this issue).